Evidence for direct action of alloxan to induce insulin resistance at the cellular level

Diabetologia

Volumn 41, Issue 11, 1998, Pages 1327-1336

  Ader, M ^a   Richey, J M ^a   Bergman, R N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Experimental diabetes; Insulin action; Insulin transport

Indexed keywords

ALLOXAN; INSULIN;

ALLOXAN DIABETES MELLITUS; ANIMAL MODEL; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DOG; DRUG MECHANISM; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HORMONE ACTION; HORMONE TRANSPORT; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LYMPH; MALE; NONHUMAN; PRIORITY JOURNAL; TARGET ORGAN; VASCULAR ENDOTHELIUM;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOGS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LYMPH; MALE;

EID: 0031739947     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051073     Document Type: Article

References (40)

1. DeFronzo RA, Hendler R, Simonson D (1982) Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795-801
2. Yki-Jarvinen H, Sahlin K, Ren JM, Koivisto VA (1990) Localization of rate-limiting defect for glucose diposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes 39: 157-167
3. Caruso G, Proietto J, Calenti A, Alford F (1983) Insulin resistance in alloxan-diabetic dogs: evidence for reversal following insulin therapy. Diabetologia 5: 273-279
4. Reaven GM, Sageman WS, Swenson RS (1977) Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency. Diabetologia 13: 459-462
5. Kahn BB (1996) Glucose transport: pivotal step in insulin action (Lilly Lecture). Diabetes 45: 1644-1654
6. Kahn BB, Charron MJ, Lodish HF, Cushman SW, Flier JS (1989) Differential regulation of two glucose transporters in adipose cells from diabetic and insulin treated diabetic rats. J Clin Invest 84: 404-411
7. Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rossetti L (1991) Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest 87: 561-570
8. Baron AD, Laakso M, Brechtel G, Edelman SV (1991) Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 73: 637-643
9. Yang YJ, Hope ID, Ader M, Bergman RN (1989) Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84: 1620-1628
10. Yang YJ, Hope ID, Ader M, Poulin RA, Bergman RN (1992) Dose response relationship between lymph insulin and glucose uptake reveals enhanced insulin sensitivity of peripheral tissues. Diabetes 41: 241-253
11. Castillo C, Bogardus C, Bergman R, Thuillez P, Lillioja S (1994) Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 93: 10-16
12. Holmäng A, Mimura K, Bjorntorp P, Lonnroth P (1997) Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Diabetes 46: 1799-1804
13. Bar RS (1992) Vascular endothelium and diabetes mellitus. In: Simionescu N, Simionescu M (eds) Endothelial Cell Dysfunctions. Plenum Press, New York, pp 363-381
14. Kwok CF, Goldstein BJ, Muller-Wieland D, Lee TS, Kahn CR, King GL (1989) Identification of persistent defects in insulin receptor structure and function in capillary endothelial cells from diabetic rats. J Clin Invest 83: 127-136
15. King GL, Johnson SM (1985) Receptor-mediated transport of insulin across endothelial cells. Science 227: 1583-1586
16. Steil GM, Ader M, Moore DM, Rebrin K, Bergman RN (1996) Transendothelial insulin transport is not saturable in vivo: no evidence for a receptor-mediated process. J Clin Invest 97: 1497-1503
17. Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall GA (1976) The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs. J Clin Invest 57: 245-255
18. Ader M, Ni T-C, Bergman RN (1997) Glucose effectiveness assessed under dynamic and steady state conditions: comparability of uptake versus production components. J Clin Invest 99: 1187-1199
19. Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924
20. Bergman RN, Hope ID, Yang YJ et al. (1989) Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 5: 411-429
21. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578-582
22. Lee A, Ader M, Bray GA, Bergman RN (1992) Diurnal variation in glucose tolerance: cyclic suppression of insulin action and insulin secretion in normal weight, but not obese subjects. Diabetes 41: 750-759
23. Finegood DT, Bergman RN (1983) Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol 244: E472-E479
24. Bradley DC, Steil GM, Bergman RN (1993) Quantitation of measurement error with Optimal Segments: basis for adaptive time course smoothing. Am J Physiol 264: E902-E911
25. Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79: 790-800
26. Ader M, Bergman RN (1987) Insulin sensitivity in the intact organism. In: Alberti KGMM, Home PD, Taylor R (eds) Bailliere's Clinics in Endocrinology and Metabolism. Bailliere Tindall, London, pp 879-910
27. Poulin RA, Steil GM, Moore DM, Ader M, Bergman RN (1994) Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes 43: 180-190
28. Bar RS, Hoak JC, Peacock ML (1978) Insulin receptors in human endothelial cells: identification and characterization. J Clin Endocrinol Metab 47: 699-702
29. Bryer-Ash M (1993) Altered distribution of insulin between intravascular and interstitial compartments in STZ-induced diabetic rats. Diabetes 42: 1528-1535
30. Hother-Nielsen O, Vaag A, Skott P, Beck-Nielsen H (1993) Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism 42: 86-93
31. Makimattila S, Virkamaki A, Groop PH et al. (1996) Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94: 1276-1282
32. Best JD, Kahn SE, Ader M, Watanabe RM, Ni T-C, Bergman RN (1996) Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030
33. Yamashita T, Mimura K, Umeda F, Kobayashi K, Hashimoto T, Nawata H (1995) Increased transendothelial permeation of albumin by high glucose concentration. Metabolism 44: 739-744
34. Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45-86
35. Ishida T, Chap Z, Chou J et al. (1984) Hepatic extraction of exogenous insulin in depancreatized conscious dogs. Am J Physiol 246: E369-E379
36. Ishida T, Lewis RM, Hartley CJ, Entman ML, Field JB (1983) Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs. Endocrinology 112: 1098-1109
37. Nijs HGT, Radder JK, Frolich M, Krans HMJ (1990) In vivo relationship between insulin clearance and action in healthy subjects and IDDM patients. Diabetes 39: 333-339
38. Berson SA, Yalow RS (1959) Quantitative aspects of reaction between insulin and insulin-binding antibody. J Clin Invest 38: 1996-2016
39. Black HE, Rosenblum IY, Capen CC (1980) Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Am J Pathol 98: 295-310
40. Williamson JR, Chang K, Tilton RG et al. (1987) Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes: prevention by aldose reductase inhibitors and castration. Diabetes 36: 813-821